Therapeutic Area

Ophthalmology

Ocular therapeutics and device research — from intravitreal injection trials to macular degeneration studies, managed with specialist endpoint tracking and patient safety protocols.

Initiate an Ophthalmology Trial

Overview

Ocular Research, Precisely Coordinated.

Mayomi Research Solutions supports ophthalmology clinical trials across a broad spectrum of ocular conditions — age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, dry eye disease, corneal disorders, and uveitis. Our coordinators work with vitreoretinal surgeons, glaucoma specialists, and optometrists to ensure protocol-compliant data collection and patient safety.

We provide specialist support for BCVA testing standardization using ETDRS charts, OCT (optical coherence tomography) scan scheduling and quality review, intraocular pressure monitoring, and the operational management of intravitreal injection procedures.

Age-related macular degeneration (wet & dry AMD) trials
Diabetic retinopathy & diabetic macular oedema studies
Glaucoma & intraocular pressure management trials
Dry eye disease & ocular surface disorder studies
Retinal prosthetic device & gene therapy trials

At a Glance

Trial Phases Phase II, III, IV

Regulatory Bodies CDSCO, FDA, EMA, DCGI

Key Endpoints BCVA (ETDRS), OCT central subfield, IOP, CSFT

Patient Population Adults 50+, diabetic patients, rare ocular

Study Types Randomised, Sham-controlled, Open-label extension

Location Bengaluru, Ophthalmology referral centres

Trial Capabilities

What We Deliver.

Specialized capabilities built for the unique demands of ophthalmology clinical research.

BCVA & OCT Endpoint Tracking

Centralised management of BCVA testing using ETDRS charts, OCT scan quality review, and central reading centre liaison to ensure consistent endpoint measurement across all study sites.

Intravitreal Injection Trials

Specialist coordination of intravitreal anti-VEGF, steroid, and gene therapy injection studies — procedural scheduling, sterility protocol compliance, and post-injection safety monitoring.

Device & Biologic Studies

Expert management of ocular device trials (Class C medical devices) and biologic therapies including gene therapy vectors, retinal prosthetics, and sustained-release ocular implants.